BGLC Stock Overview
Through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BioNexus Gene Lab Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.30 |
| 52 Week High | US$3.39 |
| 52 Week Low | US$0.28 |
| Beta | 1.87 |
| 11 Month Change | -17.81% |
| 3 Month Change | -28.57% |
| 1 Year Change | -12.28% |
| 33 Year Change | -98.68% |
| 5 Year Change | n/a |
| Change since IPO | -93.90% |
Recent News & Updates
Shareholder Returns
| BGLC | US Trade Distributors | US Market | |
|---|---|---|---|
| 7D | -7.2% | -2.1% | -1.0% |
| 1Y | -12.3% | 38.1% | 30.3% |
Return vs Industry: BGLC underperformed the US Trade Distributors industry which returned 38.5% over the past year.
Return vs Market: BGLC underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| BGLC volatility | |
|---|---|
| BGLC Average Weekly Movement | 7.9% |
| Trade Distributors Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BGLC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BGLC's weekly volatility has decreased from 50% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 30 | Lee Tan | www.bionexusgenelab.com |
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing.
BioNexus Gene Lab Corp. Fundamentals Summary
| BGLC fundamental statistics | |
|---|---|
| Market cap | US$5.13m |
| Earnings (TTM) | -US$941.56k |
| Revenue (TTM) | US$9.26m |
0.6x
P/S Ratio-5.7x
P/E RatioIs BGLC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGLC income statement (TTM) | |
|---|---|
| Revenue | US$9.26m |
| Cost of Revenue | US$8.01m |
| Gross Profit | US$1.25m |
| Other Expenses | US$2.19m |
| Earnings | -US$941.56k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 13.47% |
| Net Profit Margin | -10.17% |
| Debt/Equity Ratio | 0.2% |
How did BGLC perform over the long term?
See historical performance and comparison